• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[正常、炎症性和血性脑脊液中止血系统的纤维蛋白溶解抑制蛋白]

[Fibrinolytic inhibitory proteins of the hemostaseologic system in normal, inflammatory and bloody cerebrospinal fluid].

作者信息

Hindersin P, Heidrich R

出版信息

Psychiatr Neurol Med Psychol (Leipz). 1980 Jun;32(6):328-37.

PMID:6157172
Abstract

A quantitative immunochemical determination of the plasmin inhibitors alpha-1-antitrypsin, alpha-2-macroglobulin, and antithrombin-III of the fibronolytic system was carried out from normal, inflammatorily changed, and essentially sanguineous fluids. The low total inhibitor concentration in the cerebrospinal fluid is due to the 'restricted diffusion' caused by the blood/brain barrier function and the lacking synthesis for these proteins in the central nervous system. The inhibitor concentrations which in functional disorders of the blood/sbrain barrier and/or direct entering of blood are still--low as compared to the plasma produce a dissociation of the plasmin-inhibitor complex. The lacking interaction between the active enzyme and the inhibitor enables the occurrence of a free fibrinolytic activity in the cerebrospinal fluid.

摘要

对正常、炎症改变及主要为血性的液体进行了纤溶系统中纤溶酶抑制剂α-1-抗胰蛋白酶、α-2-巨球蛋白和抗凝血酶III的定量免疫化学测定。脑脊液中总抑制剂浓度较低是由于血脑屏障功能导致的“扩散受限”以及中枢神经系统中这些蛋白质合成的缺乏。与血浆相比,在血脑屏障功能紊乱和/或血液直接进入时抑制剂浓度仍然较低,这导致纤溶酶-抑制剂复合物解离。活性酶与抑制剂之间缺乏相互作用使得脑脊液中出现游离的纤溶活性。

相似文献

1
[Fibrinolytic inhibitory proteins of the hemostaseologic system in normal, inflammatory and bloody cerebrospinal fluid].[正常、炎症性和血性脑脊液中止血系统的纤维蛋白溶解抑制蛋白]
Psychiatr Neurol Med Psychol (Leipz). 1980 Jun;32(6):328-37.
2
Plasmin inactivation in plasma.血浆中纤溶酶的失活
Thromb Haemost. 1976 Jun 30;35(3):643-50.
3
Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.评估不同蛋白酶抑制剂在体内对纤溶酶抑制作用的相对贡献。
Thromb Haemost. 1993 Feb 1;69(2):141-6.
4
The measurement of human plasma antiplasmin activity by radial diffusion assay.通过放射免疫扩散试验测定人血浆抗纤溶酶活性。
Thromb Haemost. 1978 Apr 30;39(2):437-49.
5
[Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].[抗凝血酶III、α2-巨球蛋白、α1-抗胰蛋白酶、C1抑制剂及α2-纤溶酶抑制剂在动脉硬化性疾病和糖尿病中的变化(作者译)]
Rinsho Ketsueki. 1978 Jul;19(7):947-54.
6
Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.肾病综合征中纤溶蛋白和蛋白酶抑制蛋白的血浆水平及尿排泄情况。
J Lab Clin Med. 1994 Jul;124(1):118-24.
7
[In vitro studies to elucidate the fibrinolytic activity in cerebrospinal fluid altered by inflammation and hemorrhage and having pathologic protein values].[体外研究以阐明因炎症和出血而改变且具有病理性蛋白值的脑脊液中的纤溶活性]
Psychiatr Neurol Med Psychol (Leipz). 1977 Aug;29(8):465-73.
8
[Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].短暂性脑缺血发作患者血浆中抗纤溶能力与α2-纤溶酶抑制剂、α2-巨球蛋白、α1-抗胰蛋白酶、抗凝血酶III或C1-灭活剂浓度之间的关系(作者译)
Rinsho Byori. 1980 Mar;28(3):261-4.
9
Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.弥散性血管内凝血患者中蛋白C的激活及其在其抑制剂(蛋白C抑制剂、α1-抗胰蛋白酶和α2-巨球蛋白)之间的分布。
Thromb Haemost. 1993 May 3;69(5):448-53.
10
Blood inhibitory capacity toward exogenous plasmin.对外源性纤溶酶的血液抑制能力。
Blood Coagul Fibrinolysis. 2007 Apr;18(3):241-6. doi: 10.1097/MBC.0b013e32808738b4.